Hippocratic AI

News

Hippocratic AI has expanded with the acquisition of Grove AI, a specialist in AI used in pharma R&D, building on its patient-facing GenAI agents.

News

There's still not much sign of a recovery in financings in the digital health sect

Oncology

Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.